PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytesEric Larsen, Bruce Furie, Denisa D. Wagner et al.|Cell|1989Cited by 877
Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast CancerShaveta Vinayak, Melinda L. Telli, Sara M. Tolaney et al.|JAMA Oncology|2019Cited by 446
TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial.Shaveta Vinayak, Melinda L. Telli, Sara M. Tolaney et al.|Journal of Clinical Oncology|2018Cited by 77